ARMOR1: Study of TOK-001 to Treat Castration Resistant Prostate Cancer

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Tokai Pharmaceuticals
ClinicalTrials.gov Identifier:
NCT00959959
First received: August 14, 2009
Last updated: January 8, 2014
Last verified: September 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2012
  Primary Completion Date: August 2011 (Final data collection date for primary outcome measure)